JP2000508900A5 - - Google Patents

Download PDF

Info

Publication number
JP2000508900A5
JP2000508900A5 JP1997537224A JP53722497A JP2000508900A5 JP 2000508900 A5 JP2000508900 A5 JP 2000508900A5 JP 1997537224 A JP1997537224 A JP 1997537224A JP 53722497 A JP53722497 A JP 53722497A JP 2000508900 A5 JP2000508900 A5 JP 2000508900A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1997537224A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000508900A (ja
Filing date
Publication date
Priority claimed from US08/631,469 external-priority patent/US6221840B1/en
Application filed filed Critical
Publication of JP2000508900A publication Critical patent/JP2000508900A/ja
Publication of JP2000508900A5 publication Critical patent/JP2000508900A5/ja
Withdrawn legal-status Critical Current

Links

JP9537224A 1996-04-12 1997-04-11 腸三葉型蛋白質 Withdrawn JP2000508900A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/631,469 US6221840B1 (en) 1991-02-14 1996-04-12 Intestinal trefoil proteins
US08/631,469 1996-04-12
PCT/US1997/006004 WO1997038712A1 (en) 1996-04-12 1997-04-11 Intestinal trefoil proteins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007193980A Division JP2008037866A (ja) 1996-04-12 2007-07-26 腸三葉型蛋白質

Publications (2)

Publication Number Publication Date
JP2000508900A JP2000508900A (ja) 2000-07-18
JP2000508900A5 true JP2000508900A5 (2) 2004-12-09

Family

ID=24531337

Family Applications (3)

Application Number Title Priority Date Filing Date
JP9537224A Withdrawn JP2000508900A (ja) 1996-04-12 1997-04-11 腸三葉型蛋白質
JP2007193980A Withdrawn JP2008037866A (ja) 1996-04-12 2007-07-26 腸三葉型蛋白質
JP2009069639A Pending JP2009149687A (ja) 1996-04-12 2009-03-23 腸三葉型蛋白質

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2007193980A Withdrawn JP2008037866A (ja) 1996-04-12 2007-07-26 腸三葉型蛋白質
JP2009069639A Pending JP2009149687A (ja) 1996-04-12 2009-03-23 腸三葉型蛋白質

Country Status (12)

Country Link
US (4) US6221840B1 (2)
EP (2) EP1875922A3 (2)
JP (3) JP2000508900A (2)
AT (1) ATE364394T1 (2)
AU (1) AU729564B2 (2)
BR (1) BR9710654A (2)
CA (1) CA2251631A1 (2)
DE (1) DE69737816T2 (2)
DK (1) DK0954330T3 (2)
ES (1) ES2287952T3 (2)
PT (1) PT954330E (2)
WO (1) WO1997038712A1 (2)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221840B1 (en) * 1991-02-14 2001-04-24 The General Hospital Corporation Intestinal trefoil proteins
DK6893D0 (da) * 1993-01-21 1993-01-21 Novo Nordisk As Peptid
US6525018B1 (en) * 1999-05-17 2003-02-25 The General Hospital Corp. Treating eye disorders using intestinal trefoil proteins
US20030078205A1 (en) * 2001-07-31 2003-04-24 Podolsky Daniel K. Methods and compositions for treating and preventing distal bowel lesions
US20030185838A1 (en) * 2001-11-28 2003-10-02 Podolsky Daniel K. Methods and compositions for treating lesions of the respiratory epithelium
US20030186882A1 (en) * 2001-07-31 2003-10-02 Podolsky Daniel K. Methods and compositions for treating and preventing distal bowel lesions
PT1194554E (pt) * 1999-07-05 2007-01-31 Vlaams Interuniv Inst Biotech Libertação de péptidos trifólios
US7538082B2 (en) * 2001-04-24 2009-05-26 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
US20060189526A1 (en) * 2002-04-24 2006-08-24 Podolsky Daniel K Compositions containing an intestinal trefoil peptide and a mucoadhesive
US20040171544A1 (en) * 2001-04-24 2004-09-02 Barker Nicholas P. Trefoil domain-containing polypeptides and uses thereof
EP1842858A3 (en) * 2001-04-24 2008-04-02 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
US20030105016A1 (en) * 2001-09-06 2003-06-05 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
CA2444885A1 (en) * 2001-04-24 2002-10-31 The General Hospital Corporation Methods and compositions for treating oral and esophageal lesions
JP2004534801A (ja) * 2001-06-14 2004-11-18 ノボ　ノルディスク　アクティーゼルスカブ Ｔｆｆ２ペプチドによる粘膜修復
US20030153496A1 (en) * 2001-06-14 2003-08-14 Lars Thim Mucosal repair by TFF dimer peptides
EP1401481A1 (en) * 2001-06-14 2004-03-31 Novo Nordisk A/S Mucosal repair by tff dimer peptides
EP1925316A3 (en) * 2001-09-06 2008-06-04 The General Hospital Corporation Compositions for treating vaginal, cervical and uterine epithelial lesions
US20030181384A1 (en) * 2001-09-06 2003-09-25 Podolsky Daniel K. Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions
US20030185839A1 (en) * 2001-10-05 2003-10-02 Podolsky Daniel K. Methods and compositions for treating dermal lesions
WO2003030824A2 (en) * 2001-10-05 2003-04-17 The General Hospital Corporation Methods and compositions for treating dermal lesions
JP2005532988A (ja) * 2001-11-28 2005-11-04 ザ ジェネラル ホスピタル コーポレーション 呼吸上皮の病変を治療するための方法および組成物
US20030215431A1 (en) * 2002-02-11 2003-11-20 Lars Thim Management of mucosal viscosity by TFF monomer peptides
WO2003068817A1 (en) * 2002-02-11 2003-08-21 Novo Nordisk A/S Management of mucosal viscosity by tff monomer peptides
CN1655675A (zh) * 2002-03-26 2005-08-17 综合医院公司 利用三叶肽的联合治疗
DE10215320A1 (de) * 2002-04-02 2003-10-23 Metagen Pharmaceuticals Gmbh Verwendungen von TFF3 bindenden Substanzen zur Diagnose und Behandlung von Krebserkrankungen
US20060188471A1 (en) * 2002-10-31 2006-08-24 Podolsky Daniel K Methods of treating epithelial lesions
AU2003286844A1 (en) * 2002-10-31 2004-05-25 The General Hospital Corporation Trefoil domain-containing polypeptides and uses thereof
US6984628B2 (en) * 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
WO2005039567A1 (en) * 2003-10-08 2005-05-06 Allergan, Inc. Pharmaceutical compositions comprising alpha-2-adrenergics and trefoil factor family peptides
US20090131310A1 (en) * 2004-05-13 2009-05-21 Ho Samuel B Mucin3 egf-like domains
JP2006232754A (ja) * 2005-02-25 2006-09-07 Gi Biopolis:Kk 消化管粘膜切除後の消化管潰瘍治癒促進用スプレー剤
EP2115146B1 (en) 2007-01-12 2016-07-06 Intrexon Actobiotics NV Lactococcus promoters and uses thereof
WO2011039137A1 (en) 2009-09-29 2011-04-07 Actogenix N.V. Lactobacillus and streptococcus promoters and uses thereof
US9119869B2 (en) 2010-04-29 2015-09-01 Ronald J. Shebuski Mucin derived polypeptides
SMT202100228T1 (it) 2011-04-29 2021-05-07 Moberg Pharma Ab Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola
WO2012164083A1 (en) 2011-06-01 2012-12-06 Actogenix N.V. Polycistronic expression system for bacteria
CA3011331C (en) 2016-01-14 2025-05-13 Intrexon Actobiotics N.V. Compositions and methods for the treatment of type 1 diabetes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2003A (en) * 1841-03-12 Improvement in horizontal windivhlls
US2007A (en) * 1841-03-16 Improvement in the mode of harvesting grain
US4370317A (en) 1980-09-10 1983-01-25 Novo Industri A/S Pancreatic spasmolytic polypeptide
US5192676A (en) * 1991-02-05 1993-03-09 New England Biolabs, Inc. Type ii restriction endonuclease, asci, obtainable from arthrobacter species and a process for producing the same
US6063755A (en) * 1991-02-14 2000-05-16 The General Hospital Corporation Intestinal trefoil proteins
US6221840B1 (en) * 1991-02-14 2001-04-24 The General Hospital Corporation Intestinal trefoil proteins
AU1415892A (en) 1991-02-14 1992-09-15 General Hospital Corporation, The Intestinal trefoil proteins
DE4132005A1 (de) * 1991-09-26 1993-04-01 Merck Patent Gmbh Kombination enthaltend wachstumsfaktoren und polyelektrolyte
DK6893D0 (da) * 1993-01-21 1993-01-21 Novo Nordisk As Peptid
US5563046A (en) * 1993-08-02 1996-10-08 Celtrix Pharmaceuticals, Inc. Fusion polypeptides and proteins
CN1070867C (zh) 1994-08-26 2001-09-12 诺沃挪第克公司 三叶形肽双体
US6525018B1 (en) * 1999-05-17 2003-02-25 The General Hospital Corp. Treating eye disorders using intestinal trefoil proteins
US6426404B1 (en) * 1997-08-25 2002-07-30 The General Hospital Corporation Receptor for intestinal trefoil factor
US6372439B2 (en) * 1998-10-01 2002-04-16 James R. Goldenring Screen for gastric adenocarcinoma
AU2002221565A1 (en) * 2000-12-08 2002-06-18 Novo-Nordisk A/S Trefoil factor 2 (tff2) peptides with moiety attached to asn15
US20030153496A1 (en) * 2001-06-14 2003-08-14 Lars Thim Mucosal repair by TFF dimer peptides
JP2004534801A (ja) * 2001-06-14 2004-11-18 ノボ　ノルディスク　アクティーゼルスカブ Ｔｆｆ２ペプチドによる粘膜修復
US20030215431A1 (en) * 2002-02-11 2003-11-20 Lars Thim Management of mucosal viscosity by TFF monomer peptides
US6984628B2 (en) * 2003-07-15 2006-01-10 Allergan, Inc. Ophthalmic compositions comprising trefoil factor family peptides
WO2005039640A1 (en) * 2003-10-03 2005-05-06 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
AU2004283091A1 (en) * 2003-10-03 2005-05-06 Allergan, Inc. Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia

Similar Documents

Publication Publication Date Title
JP2001505705A5 (2)
JP2000517231A5 (2)
JP2000507565A5 (2)
JP2000506628A5 (2)
JP2000511377A5 (2)
JP2000506667A5 (2)
JP2001501471A5 (2)
JP2000515062A5 (2)
JP2001500477A5 (2)
JP2000511016A5 (2)
JP2000507745A5 (2)
JP2001505855A5 (2)
JP2000506861A5 (2)
JP2000512231A5 (2)
JP2001504996A5 (2)
JP2001500092A5 (2)
JP2000512342A5 (2)
JP2000516592A5 (2)
JP2001503448A5 (2)
JP2000508681A5 (2)
JP2001502315A5 (2)
JP2000516610A5 (2)
JP2001504189A5 (2)
JP2000512651A5 (2)
JP2001505207A5 (2)